A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1500 participants.
Also called NCT07784270
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,500 participants
- Sponsor
- Registry
-
NCT07784270 -
2025-524616-11
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Argentina, Australia, Canada, Chile, China, Germany, Hungary, India, Japan, Poland, Slovakia, South Korea, Spain, Taiwan, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT07784270. Randomized; quadruple masking; primary purpose treatment. Start 2026-08-20 (actual); primary completion 2028-08-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Acronym
- SELENE 2
- Condition
- Obesity or Overweight
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Lenbelintide
- Intervention (Drug)
- Placebo
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct07784270- Content hash
0417af705ba83a1510ca7f5d644813851cc3d23437df0cea6fa3400d991389d1